Kimberly-Clark (KMB) Earnings Date & Reports

Kimberly-Clark delivered Q1 2026 net sales of $4.163 billion, a 2.7% increase from the prior year, exceeding consensus estimates around $4.1 billion. Organic sales growth reached 2.5%, driven by 3.0% higher volume-plus-mix, though tempered by 0.5% lower pricing and impacts from exiting the U.S. private label diaper business. North America sales dipped 0.6% to $2.651 billion but showed 1.8% organic growth, while International Personal Care surged 9.1% to $1.512 billion with 4.0% organic gains.

GAAP diluted EPS from continuing operations was $1.70, up from $1.39, while adjusted EPS from continuing operations was $1.60, slightly down from $1.62. Including discontinued operations, adjusted diluted EPS attributable to Kimberly-Clark hit $1.97, beating expectations of $1.92-$1.93 and up 2.1% year-over-year. Adjusted operating profit climbed 3.7% to $732 million, aided by productivity savings, lower marketing expenses, and currency benefits, though gross margins dipped to 37.9% adjusted due to supply chain investments and pricing dynamics.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your stock analysis workflow.

Market Reaction and Investor Sentiment

Following the Q1 2026 earnings release on April 28, Kimberly-Clark's stock saw a modest premarket uptick of about 0.34% to $98.58, reflecting positive reception to the earnings beat and reaffirmed guidance despite some margin pressures. Investor sentiment appeared cautiously optimistic, with focus on robust organic growth and cash flow strength outweighing adjusted tax rate increases. Trading volume was elevated, signaling keen interest in the results amid broader consumer staples sector performance.

Forward Outlook and Key Factors to Monitor

Kimberly-Clark reaffirmed its 2026 outlook, projecting organic sales growth in line with or ahead of category/country growth rates (around 2.5% weighted average). Adjusted operating profit is expected to rise mid-to-high single digits on a constant-currency basis, supported by productivity gains and equity income growth of about 40% versus 2025.

Investors should track progress on the Kenvue acquisition, expected to close mid-year, and its integration impacts. Upcoming catalysts include Q2 results in late July, potential separation costs for the IFP (In-Full Packaging) transaction, and ongoing 2024 Transformation Initiative charges. Demand signals in personal care categories, pricing discipline, and supply chain efficiencies will be pivotal amid macroeconomic uncertainties.

Margin trends remain a watchpoint, with investments in innovation and new product trials pressuring gross margins short-term, offset by cost savings. Currency fluctuations could add ~170 basis points favorable impact to EPS. Overall, execution on volume-driven growth and cash generation will shape the trajectory through year-end.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations